EUR ARCH OTO-RHINO-L 润色咨询

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

出版年份:1990 年文章数:5248 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:10.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2022-06-14 ms5000001694660811

    请问最近这个杂志accept后多久发Proof过来?

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2024-02-16 13dd001bm51暂无昵称 来自四川省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:鼻咽癌
    经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2023-06-16 ms9000001618923574 来自福建省

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向:头颈肿瘤
    经验分享:这个期刊效率很高,前后不到1个月

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2024-02-02 ms8000002033436461 来自江苏省

    审稿速度:12.0 | 投稿命中率:5.0
    经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2024-01-29 ms5000001463059972 来自广东省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:鼻咽癌
    经验分享:送外审2个月,因为找不到审稿人拒稿了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2023-06-27 ms3000000261060700 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:耳科;眩晕
    经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2022-10-08 ms5000001292778018

    已经接收了 继续加油吧

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2024-01-03 ms1000000297035092 来自山西省

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2018-11-27 Dr_Hemis_AI

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1226327, encodeId=7e4c122632edc, content=请问最近这个杂志accept后多久发Proof过来?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db285425595, createdName=ms5000001694660811, createdTime=Tue Jun 14 09:12:27 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187608, encodeId=fd3c218e60812, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:鼻咽癌<br>经验分享:编辑和审稿人都很友好,前后不到两个月接收,很推荐的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11c84221964, createdName=13dd001bm51暂无昵称, createdTime=Fri Feb 16 09:27:56 CST 2024, time=2024-02-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143184, encodeId=f9002143184de, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:头颈肿瘤<br>经验分享:这个期刊效率很高,前后不到1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2845722447, createdName=ms9000001618923574, createdTime=Fri Jun 16 19:33:54 CST 2023, time=2023-06-16, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185527, encodeId=db6b218552ec2, content=审稿速度:12.0 | 投稿命中率:5.0<br>经验分享:23年6月小修返回 24年1月还在under review 有没有大佬知道这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Fri Feb 02 17:11:12 CST 2024, time=2024-02-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻咽癌<br>经验分享:送外审2个月,因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145026, encodeId=419e214502689, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:耳科;眩晕<br>经验分享:4月24投稿,5月23送外审,6月25审稿结束,6月27接到小修邮件,但是只有1位审稿人,哭死估计还得再送外审,希望我好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bb45377712, createdName=ms3000000261060700, createdTime=Tue Jun 27 15:24:18 CST 2023, time=2023-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2092442, encodeId=256820924423b, content=已经接收了 继续加油吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Sat Oct 08 10:37:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179082, encodeId=562d21e908227, content= 的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Wed Jan 03 20:17:54 CST 2024, time=2024-01-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=563689, encodeId=55d7563689a2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:投稿12天, 两个reviewers 意见都很好。 直接接受。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b421641846, createdName=Dr_Hemis_AI, createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152995, encodeId=8a6821529952e, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:鼻腔鼻窦恶性肿瘤<br>经验分享:2023.7.6 submit<br>2023.7.9 with edtior<br>2023.7.12 under review<br>2023.7.24 under review 但status 发生变化<br>2023.8.7 under review 但status 发生变化<br>2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60588215075, createdName=ms6000000611668045, createdTime=Wed Aug 16 09:01:15 CST 2023, time=2023-08-16, status=1, ipAttribution=宁夏)]
    2023-08-16 ms6000000611668045 来自宁夏

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:鼻腔鼻窦恶性肿瘤
    经验分享:2023.7.6 submit
    2023.7.9 with edtior
    2023.7.12 under review
    2023.7.24 under review 但status 发生变化
    2023.8.7 under review 但status 发生变化
    2023.8.17 外审已经一个多月了,还没消息,等的很着急,8月底之前等着杂志回复呢,要不然考核就凉凉了

    1

    展开1条回复
共150条页码: 1/15页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分